Evogene (NASDAQ:EVGN) Now Covered by StockNews.com
Analysts at StockNews.com assumed coverage on shares of Evogene (NASDAQ:EVGN – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the biotechnology company’s stock. Separately, Alliance Global Partners reiterated a “buy” rating on shares of Evogene in a research note on Friday, March 7th. Check […]
